Hyperemesis and a high water bill.

Hyperemesis is a severe and persistent form of vomiting that can have many underlying causes. Prior research has shown that common causes include pregnancy, gastrointestinal disorders, and medication side effects. However, some cases remain unexplained despite extensive diagnostic testing. Cannabinoid hyperemesis syndrome was first described in 2004 and is a rare but increasingly recognized condition. It is associated with chronic cannabis use and is characterized by cyclical vomiting and compulsive bathing behavior. This condition is often underdiagnosed due to its similarity to other gastrointestinal disorders. No prior work had resolved the full clinical presentation in some regions. This gap motivated further case documentation and awareness. That uncertainty drove the need for more clinical recognition in diverse populations.

The aim of this case report is to document a rare clinical presentation of hyperemesis in a nonpregnant male patient. The specific problem is the difficulty in diagnosing hyperemesis when standard approaches fail to identify a cause. The motivation is to highlight an underrecognized syndrome that may be overlooked in clinical settings. The authors propose that chronic cannabis use combined with abnormal bathing behavior could indicate cannabinoid hyperemesis syndrome. This case adds to the limited literature on the condition in Europe. The authors suggest that awareness of this syndrome could prevent unnecessary diagnostic testing. The study also emphasizes the importance of patient history in differential diagnosis. The authors propose that clinicians should consider this syndrome when encountering unexplained vomiting.

The study is a single case report based on clinical observation and patient history. The patient's medical records were reviewed, and a physical examination was conducted. The patient reported persistent vomiting and abnormal bathing behavior. A range of diagnostic tests was performed, including blood work and imaging. No pathological findings were identified. The patient's cannabis use was documented through self-report and urine analysis. The clinical findings were compared to established criteria for cannabinoid hyperemesis syndrome. After diagnosis, the patient underwent a detoxification process. Symptom resolution was monitored over time.

The patient experienced persistent vomiting that did not respond to standard treatments. He reported chronic cannabis use and took hot showers multiple times daily for over an hour. No pathological findings were identified through laboratory or imaging tests. The patient's symptoms resolved after detoxification from cannabis. The authors propose that the diagnosis of cannabinoid hyperemesis syndrome was confirmed through clinical correlation. This is the first reported case of the syndrome in Germany. The patient remained symptom-free after discontinuing cannabis use. The authors suggest that this case supports the clinical recognition of the syndrome in new regions.

The authors propose that chronic cannabis use combined with compulsive bathing behavior may indicate cannabinoid hyperemesis syndrome. This case supports the clinical recognition of the syndrome in Germany. The authors suggest that clinicians should consider this diagnosis in unexplained cases of hyperemesis. The authors propose that patient history is essential in identifying this condition. The authors suggest that awareness of this syndrome could prevent unnecessary diagnostic testing. The authors propose that this case adds to the limited literature on the syndrome in Europe. The authors suggest that further case reports may improve clinical recognition. The authors propose that this case supports the importance of differential diagnosis in hyperemesis.